Présentation de l'entreprise
U-BX Technology Ltd., trading under the ticker UBXG, operates within the Technology sector with a specific focus on the Software - Infrastructure industry, providing value-added services to businesses in the Chinese insurance sector. The company leverages artificial intelligence-driven technology to deliver digital promotion services, risk assessment capabilities, and value-added bundled benefits to its clients. As of the latest data, the entity maintains a market capitalization of $36.64M and employs a workforce of 15 individuals, reflecting a small-cap profile typical of niche infrastructure providers. The annual revenue reported over the trailing twelve months stands at $24.04M, which, when combined with the market cap, indicates a valuation multiple that is not heavily dependent on immediate revenue expansion but rather on the specific utility of its software solutions. The relatively low employee count of 15 suggests a highly specialized or automated operational model, while the market cap of $36.64M positions the company as a micro-cap asset within the broader technology landscape, implying limited liquidity and higher volatility compared to large-cap peers.
Santé financière
The company reported a revenue of $24.04M for the trailing twelve months, yet this generated a net income of $-13,241,861, revealing a significant cost structure where expenses substantially exceed gross earnings. The EBITDA for the same period was $-12,833,699, indicating that operating cash flows before interest and taxes are also deeply negative, which underscores the current phase of high burn rate or heavy investment in infrastructure. Furthermore, the free cash flow stands at $-17,057,336, which signifies a substantial cash outflow that limits the company's immediate financial flexibility to fund operations without external capital injection. Margin analysis shows a gross margin of 0.3%, an operating margin of -87.6%, and a profit margin of -55.1%, collectively indicating that the company struggles to retain revenue due to high operational costs or low pricing power relative to its cost of goods sold. On the balance sheet, the company holds $9.87M in cash against $0 in debt, resulting in a debt-to-equity ratio listed as N/A due to the absence of debt, which presents a conservative leverage profile despite the negative earnings. The current ratio is a robust 20.55, suggesting that the company possesses an immense ability to cover its short-term liabilities with its current assets, though this figure is unusually high and may indicate significant idle cash reserves. Additionally, the return on equity is -46.6% and the return on assets is -26.5%, metrics that reveal that management is currently destroying shareholder value and utilizing assets inefficiently to generate profit.
Évaluation de la valorisation
The trailing P/E ratio and forward P/E ratio are both listed as N/A because the company reports a net loss, meaning traditional earnings-based valuation metrics are not applicable at this time. The price-to-book ratio is 1.32, which indicates that the market values the company at 132% of its book value, suggesting a market premium that investors are placing on the firm's intangible assets or future growth potential despite current losses. The price-to-sales ratio is 1.52, and the EV/EBITDA is -1.91, providing alternative perspectives where the valuation is anchored to revenue rather than earnings, implying that investors are pricing the stock based on top-line growth prospects or strategic positioning in the AI insurance space. Regarding price movement, the 52-week high is $4.55 and the 52-week low is $1.15, meaning the current share price sits somewhere within this range, reflecting the volatility typical of small-cap technology stocks with no debt but negative earnings. The beta value is listed as N/A, which prevents a direct comparison of price volatility relative to the broader market, but the wide spread between the high and low prices of $3.40 suggests significant intraperiod price swings.
Growth & Income
The revenue growth year-over-year is -32.6%, while the earnings growth year-over-year is N/A due to the lack of prior period earnings data for comparison. This contraction in revenue implies that the company is currently shrinking its top line, which is a critical factor to consider alongside the negative earnings trajectory and the inability to reinvest profits for expansion. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which indicates that all available cash flows are retained within the company to support operations and potentially fund future growth initiatives rather than being distributed to shareholders. The overall growth and income profile is characterized by negative revenue expansion and zero dividend yield, presenting a high-risk scenario for income-oriented investors while potentially offering speculative upside for those betting on a future turnaround in the Chinese insurance software market. The combination of declining revenue, negative profitability, and no dividend payout underscores the speculative nature of the investment, where value is derived entirely from the expectation of future operational improvements rather than current financial performance or income generation.